DJIA 17,550.69 -47.51 -0.27%
NASDAQ 5,105.55 -9.84 -0.19%
S&P 500 2,093.32 -4.72 -0.22%
market minute promo

Celgene (NASDAQ: CELG)



company name or ticker

5 Reasons Celgene Corporation Is a Buy

Celgene has been a monster stock for investors, and this Fool thinks the future continues to look bright. Here are five reasons Celgene is a buy today.

Acceleron Pharma Has 2 Drug Candidates That Could Become Blockbusters

What's in Store for Celgene (CELG) This Earnings Season? - Analyst Blog

A Few Key Points I Am Watching For From Gilead Sciences

Celgene Buys Receptos. Is Arena Pharmaceuticals Next?

Both biotechs have S1P1 receptor drugs, but they're not created equal.

Johnson & Johnson - Short Term Headwinds, Solid Long Term Prospects

Piper Jaffray Still Overweight Biogen But Notes It's Least-Preferred Play; Hikes Celgene Target

Celgene (CELG) Hits New Lifetime High

3 Questions Investors Should Ask When Celgene Reports Its Second-Quarter Results

Celgene's Q2 report is right around the corner. Here are three questions investors should keep in mind.

Jim Cramer's Top Takeaways: Celgene, Facebook, Amazon.com, Netflix, Google

See More Articles...